Turner's syndrome

被引:230
作者
Ranke, MB [1 ]
Saenger, P
机构
[1] Univ Tubingen, Childrens Hosp, Paediat Endocrinol Sect, D-72076 Tubingen, Germany
[2] Yeshiva Univ Albert Einstein Coll Med, Montefiore Med Ctr, Dept Pediat, Div Pediat Endocrinol, New York, NY 10033 USA
关键词
D O I
10.1016/S0140-6736(01)05487-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Before chromosomal analysis became available, the diagnosis of Turner's syndrome was based on the characteristics Independently described by Otto Ullrich and Henry Turner, such as short stature, gonadal dysgenesis, typical, visible dysmorphic stigmata, and abnormalities in organs, which present in individuals with a female phenotype. Today, Turner's syndrome or Ullrich-Turner's syndrome may be defined as the combination of characteristic physical features and complete or part absence of one of the X chromosomes, frequently accompanied by cell-line mosaicism. The increasing interest In Turner's syndrome over the past two decades has been motivated both by the quest for a model by which the multi-faceted features of this disorder can be understood, and the endeavour to provide life-long support to the patient. New developments in research allow patients with Turner's syndrome to have multidisciplinary care.
引用
收藏
页码:309 / 314
页数:6
相关论文
共 67 条
  • [1] Biochemical liver abnormalities in Turner's syndrome
    Albareda, MM
    Gallego, A
    Enríquez, J
    Rodríguez, JL
    Webb, SM
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (09) : 1037 - 1039
  • [2] Long-term ovarian function in sheep after ovariectomy and transplantation of autografts stored at -196 C
    Baird, DT
    Webb, R
    Campbell, BK
    Harkness, LM
    Gosden, RG
    [J]. ENDOCRINOLOGY, 1999, 140 (01) : 462 - 471
  • [3] SHOX mutations in dyschondrosteosis (Leri-Weill syndrome)
    Belin, V
    Cusin, V
    Viot, G
    Girlich, D
    Toutain, A
    Moncla, A
    Vekemans, M
    Le Merrer, M
    Munnich, A
    Cormier-Daire, V
    [J]. NATURE GENETICS, 1998, 19 (01) : 67 - 69
  • [4] Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone
    Binder, G
    Schwarze, CP
    Ranke, MB
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) : 245 - 249
  • [5] Distinctive patterns of memory function in subgroups of females with Turner syndrome: evidence for imprinted loci on the X-chromosome affecting neurodevelopment
    Bishop, DVM
    Canning, E
    Elgar, K
    Morris, E
    Jacobs, PA
    Skuse, DH
    [J]. NEUROPSYCHOLOGIA, 2000, 38 (05) : 712 - 721
  • [6] REGIONAL CEREBRAL GLUCOSE-METABOLISM IN TURNER SYNDROME
    CLARK, C
    KLONOFF, H
    HAYDEN, M
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1990, 17 (02) : 140 - 144
  • [7] The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome
    Clement-Jones, M
    Schiller, S
    Rao, E
    Blaschke, RJ
    Zuniga, A
    Zeller, R
    Robson, SC
    Binder, G
    Glass, I
    Strachan, T
    Lindsay, S
    Rappold, GA
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (05) : 695 - 702
  • [8] CONWAY GS, 2000, OPTIMIZING HLTH CARE, P295
  • [9] DEKERDANET M, 1994, CLIN ENDOCRINOL, V41, P673
  • [10] Growth hormone therapy in Turner syndrome - Current uncertainties and future strategies
    Donaldson, MDC
    [J]. HORMONE RESEARCH, 1997, 48 : 35 - 44